Wednesday Aug 29, 2018

Nusinersen for SMA

Elizabeth Highton (JNNP Podcast Editor) speaks with Dr. Michelle Farrar (University of New South Wales) discussing nusinersen, the first disease-modifying therapy for spinal muscular atrophy type 1 (SMA). https://jnnp.bmj.com/content/89/9/937

Copyright 2023 All rights reserved.

Version: 20241125